Bellevue Group’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,300
| Closed | -$172K | – | 171 |
|
|
2024
Q3 | $172K | Sell |
9,300
-10,400
| -53% | -$192K | ﹤0.01% | 150 |
|
|
2024
Q2 | $424K | Hold |
19,700
| – | – | 0.01% | 132 |
|
|
2024
Q1 | $531K | Sell |
19,700
-1,300
| -6% | -$35K | 0.01% | 129 |
|
|
2023
Q4 | $629K | Buy |
+21,000
| New | +$629K | 0.01% | 130 |
|
|
2023
Q3 | – | Sell |
-55,600
| Closed | -$1.1M | – | 162 |
|
|
2023
Q2 | $1.1M | Buy |
55,600
+19,000
| +52% | +$378K | 0.02% | 128 |
|
|
2023
Q1 | $627K | Hold |
36,600
| – | – | 0.01% | 138 |
|
|
2022
Q4 | $716K | Buy |
+36,600
| New | +$716K | 0.01% | 145 |
|